ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy

NCT03122262 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1110

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: Dolutegravir
DRUG: Tenofovir Alafenamide
DRUG: Truvada
DRUG: Atripla

Sponsor

Professor Francois Venter